Skip to main content
Nanologica logo

Nanologica — Investor Relations & Filings

Ticker · NICA ISIN · SE0005454873 LEI · 54930017L41C7P87LP22 ST Manufacturing
Open in API
Filings indexed 181 across all filing types
Latest filing 2026-05-21 Declaration of Voting R…
Country SE Sweden
Listing ST NICA

About Nanologica

https://nanologica.com/

Nanologica is a life science tools company that develops, manufactures, and sells advanced consumables to pharmaceutical manufacturers. The company specializes in nanoporous silica particles for preparative chromatography, a critical step in drug production. Its core product, NLAB Saga®, is a spherical, porous silica media engineered for the large-scale purification of peptide drugs, such as insulin and GLP-1 analogues used to treat diabetes and obesity. The product's high mechanical and chemical stability provides effective purification and a long lifetime, which increases productivity and reduces costs for pharmaceutical manufacturers. Nanologica's mission is to lower the manufacturing costs of these drugs, thereby increasing patient access to life-saving treatments. The company is also developing a broader portfolio of purification media.

Recent filings

Filing Released Lang Actions
Kommuniké årsstämma Nanologica AB (publ)
Declaration of Voting Results & Voting Rights Announcements Classification · 90% confidence The document is a press release titled “Kommuniké årsstämma Nanologica AB (publ)” summarizing the resolutions adopted at the Annual General Meeting held on 21 May 2026 (e.g., approval of financial statements, discharge of liability, election of board members, amendments to articles, share capital reduction, issuance authorizations). This is not the full AGM materials or slides (AGM-R) but rather the official results of shareholder votes at the AGM, fitting the Declaration of Voting Results category.
2026-05-21 Swedish
Bulletin from the Annual General Meeting 2026 Nanologica AB (publ)
AGM Information Classification · 96% confidence The document is a press release summarizing the resolutions adopted at the company’s Annual General Meeting (AGM), including approval of financial statements, board elections, fees, auditor appointments, amendments of articles of association, share capital reduction, and authorizations. It is not the full annual report, nor an earnings release, but the AGM bulletin/minutes. Therefore it is classified as AGM Information (Code: AGM-R).
2026-05-21 English
Interim / Quarterly Report 2026
Interim / Quarterly Report Classification · 93% confidence The document is a comprehensive financial report for Nanologica AB covering Q1 2026, including detailed financial statements, key performance metrics, segment analyses, cash flows, balance sheet items and narrative management commentary. It is clearly an interim/quarterly report (Delårsrapport Q1 2026) containing substantive financial data and analysis. Therefore, it should be classified as an Interim / Quarterly Report (IR). Q1 2026
2026-05-20 Swedish
Interim / Quarterly Report 2026
Interim / Quarterly Report Classification · 95% confidence The document is titled “Interim Report Q1 2026” and provides a full set of quarterly financial statements, key figures, segment reporting, comparative periods, cash flow, balance sheet details, management commentary, and notes. It is not merely an announcement or a short earnings teaser but a comprehensive quarter-end report. This clearly matches the definition of an Interim/Quarterly Report (IR). Q1 2026
2026-05-20 English
NUMBER OF SHARES AND VOTES IN NANOLOGICA AB (PUBL)
Share Issue/Capital Change Classification · 95% confidence The document is a press release dated April 30, 2026, announcing the change in the number of registered shares and votes in Nanologica AB due to registration of share issues resolved by the Board and approved by an Extraordinary General Meeting. It details the increase in shares and share capital but does not contain financial statements or detailed financial data. The document is short (2474 characters) and serves as an announcement of a capital change rather than the capital change report itself. Therefore, it fits the category of Share Issue/Capital Change announcement.
2026-04-30 English
ANTAL AKTIER OCH RÖSTER I NANOLOGICA AB (PUBL)
Share Issue/Capital Change Classification · 95% confidence The document is a press release dated April 30, 2026, announcing the change in the number of registered shares and votes in Nanologica AB due to the registration of share emissions approved earlier in the year. It details the increase in shares and share capital but does not contain financial statements or detailed financial data. The document is short (2417 characters) and serves as an announcement of a capital change event rather than a full report. Therefore, it fits the category of Share Issue/Capital Change (SHA).
2026-04-30 Swedish

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.